Jeanne Thoma

Ms. Thoma has been a member of the Board since August 2020. She is President and CEO of SPI Pharma Inc., a global pharmaceuticals ingredients company and an innovative solutions provider of ingredients and drug delivery systems. Prior to joining SPI in January 2017, Ms. Thoma worked at Lonza AG, a Switzerland-based biotech company, where she held positions of increasing responsibility, including as President and COO of the Microbial Control Business Sector, and then as an independent consultant to various companies. Prior to joining Lonza in 2007, Ms. Thoma spent 14 years at BASF Corp. in the Pharma Solutions business where she held various leadership positions in Sales, Marketing and Operations. Ms. Thoma is a member of the Board of Advisors for the Drug Chemical and Associated Technologies Association. Ms. Thoma holds a B.S. from Montclair State University and an M.B.A. from Fairleigh Dickinson University.